Filter Results
:
(6)
Show Results For
- All HBS Web (13)
- Faculty Publications (4)
Show Results For
- All HBS Web (13)
- Faculty Publications (4)
Page 1 of
6
Results
Sort by
- February 2019 (Revised September 2021)
- Case
The a2 Milk Company
By: Benjamin C. Esty and Daniel Fisher
The a2 Milk Company (a2MC) became the most valuable company listed on the New Zealand stock exchange in 2018 by capitalizing on a biochemical discovery related to the protein composition of cow's milk. Because many people find the A1 protein difficult to digest, and...
View Details
Keywords:
Judo Economics;
Market Entry;
Innovation;
Barriers To Response;
Industry Attractiveness;
Advantage Horizon;
Sustainability;
First-mover Advantage;
Scope;
Strategy Execution;
Strategic Evolution;
Biochemistry;
Genetics;
Branding;
Commodity;
Milk;
Dairy;
Infant Formula;
Farming;
Porter's Five Forces;
Competitive Advantage;
Corporate Strategy;
Value Creation;
Competition;
Disruption;
Innovation and Invention;
Five Forces Framework;
Market Entry and Exit
Esty, Benjamin C., and Daniel Fisher. "The a2 Milk Company." Harvard Business School Case 719-424, February 2019. (Revised September 2021.)
- January 2019 (Revised February 2019)
- Supplement
The a2 Milk Company
By: Benjamin C. Esty, Daniel Fisher and Greg Saldutte
The a2 Milk Company (a2MC) became the most valuable company listed on the New Zealand stock exchange in 2018 by capitalizing on a biochemical discovery related to the protein composition of cow's milk. Because many people find the A1 protein difficult to digest, and...
View Details
Keywords:
Judo Economics;
Market Entry;
Innovation;
Barriers To Response;
Industry Attractiveness;
Advantage Horizon;
Sustainability;
First-mover Advantage;
Scope;
Strategy Execution;
Strategic Evolution;
Biochemistry;
Genetics;
Branding;
Commodity;
Milk;
Dairy;
Infant Formula;
Farming;
Porter's Five Forces;
Competitive Advantage;
Corporate Strategy;
Value Creation;
Competition;
Market Entry and Exit;
Disruption;
Innovation and Invention;
Five Forces Framework;
Consumer Products Industry;
New Zealand;
Australia;
China
- April 2019
- Teaching Note
The a2 Milk Company
By: Benjamin C. Esty and Daniel Fisher
The a2 Milk Company (a2MC) became the most valuable company listed on the New Zealand stock exchange in 2018 by capitalizing on a biochemical discovery related to the protein composition of cow's milk. Because many people find the A1 protein difficult to digest, and...
View Details
Keywords:
Judo Economics;
Market Entry;
Innovation;
Barriers To Response;
Industry Attractiveness;
Advantage Horizon;
Sustainability;
First-mover Advantage;
Scope;
Strategy Execution;
Strategic Evolution;
Biochemistry;
Genetics;
Branding;
Commodity;
Milk;
Dairy;
Infant Formula;
Farming;
Porter's Five Forces;
Market Entry and Exit;
Disruption;
Innovation and Invention;
Competitive Advantage;
Corporate Strategy;
Value Creation;
Competition;
Brands and Branding;
Five Forces Framework;
Consumer Products Industry;
New Zealand;
Australia;
China
- January 2020
- Case
Celata Bioinnovations
By: John R. Wells and Benjamin Weinstock
In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process....
View Details
Keywords:
Drug Development;
Drug Discovery;
Drug Trials;
Pharmaceutical Companies;
Pharmaceutical Company;
Pharmaceuticals;
Therapeutics;
Biologics;
Biotech;
Biotechnology;
Biopharmacy Company;
Biochemistry;
Technology Commercialization;
Technology Companies;
Drug Testing;
Startup;
Start-up;
Startups;
Start-ups;
Startup Financing;
Strategic Decision Making;
Strategic Decisions;
Strategic Evolution;
FDA;
Food And Drug Administration;
Clinical Trials;
Disease Management;
Market Attractiveness;
Market Entry;
Market Opportunities;
Health Disorders;
Technological Innovation;
Information Technology;
Commercialization;
Business Startups;
Finance;
Decision Making;
Strategy;
Market Entry and Exit;
Opportunities;
Pharmaceutical Industry;
Biotechnology Industry
Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
- 21 Nov 2023
- Op-Ed
The Beauty Industry: Products for a Healthy Glow or a Compact for Harm?
In my recently published book Deeply Responsible Business, I write about business leaders since the 19th century who have acted responsibly, often by putting the welfare of their communities above the idea of maximizing profits. I make a sharp distinction between...
View Details